BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16375696)

  • 1. Hormonal effects on drug metabolism through the CYP system: perspectives on their potential significance in the era of pharmacogenomics.
    Sarlis NJ; Gourgiotis L
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):439-48. PubMed ID: 16375696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 in Pharmacogenetics: An Update.
    Tornio A; Backman JT
    Adv Pharmacol; 2018; 83():3-32. PubMed ID: 29801580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
    Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
    Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
    Hakkola J; Pelkonen O; Pasanen M; Raunio H
    Crit Rev Toxicol; 1998 Jan; 28(1):35-72. PubMed ID: 9493761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates.
    Derks M; Fowler S; Kuhlmann O
    Curr Med Res Opin; 2009 Apr; 25(4):891-902. PubMed ID: 19245299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions.
    Urichuk L; Prior TI; Dursun S; Baker G
    Curr Drug Metab; 2008 Jun; 9(5):410-8. PubMed ID: 18537577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Khat (Catha edulis) use on catalytic activities of major drug-metabolizing cytochrome P450 enzymes and implication of pharmacogenetic variations.
    Bedada W; de Andrés F; Engidawork E; Hussein J; LLerena A; Aklillu E
    Sci Rep; 2018 Aug; 8(1):12726. PubMed ID: 30143732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
    Manikandan P; Nagini S
    Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
    Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
    Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic detoxification of bakuchiol is mediated by cytochrome P450 enzymes in human liver microsomes].
    Li AF; Shen GL; Jiao SY; Li H; Wang Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):431-6. PubMed ID: 22692316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 gene polymorphism and cancer.
    Agundez JA
    Curr Drug Metab; 2004 Jun; 5(3):211-24. PubMed ID: 15180491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine.
    Fang J; Coutts RT; McKenna KF; Baker GB
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):592-9. PubMed ID: 9840430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonation of hepatic cytochrome P-450 expression and regulation.
    Oinonen T; Lindros KO
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):17-35. PubMed ID: 9405271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delamanid does not inhibit or induce cytochrome p450 enzymes in vitro.
    Shimokawa Y; Sasahara K; Yoda N; Mizuno K; Umehara K
    Biol Pharm Bull; 2014; 37(11):1727-35. PubMed ID: 25366478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: the effect of the expression of cytochrome b(5) with recombinant P450 enzymes.
    Emoto C; Iwasaki K
    Xenobiotica; 2007 Sep; 37(9):986-99. PubMed ID: 17896325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 pharmacogenetics and cancer.
    Rodriguez-Antona C; Ingelman-Sundberg M
    Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase.
    Fujita K; Nakayama K; Yamazaki Y; Tsuruma K; Yamada M; Nohmi T; Kamataki T
    Environ Mol Mutagen; 2001; 38(4):329-38. PubMed ID: 11774365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.